InvestorsHub Logo
Followers 594
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

Re: trebor4 post# 10113

Friday, 03/21/2014 9:41:51 AM

Friday, March 21, 2014 9:41:51 AM

Post# of 48316
There is also the possibility that they submitted the same Melanoma abstract to both ASCO and ASGCT hoping the one would be accepted. If that is the case then the ASCO submittal would have to be withdrawn. Both ASCO and ASGCT are excellent Peer Review presentations so it would be a win-win in either event.

AS well the possibility that ASCO abstract was for MCC TLD if enough data points had been gathered in Jan 2014.

Looking for clarification now.